TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC DEPTH OF ANESTHESIA MONITORING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 TECHNOLOGY LIFELINE CURVE
2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.10 DBMR MARKET POSITION GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 NOCICEPTION MONITORING MARKET OVERVIEW
4.1.1 DEFINITION
4.2 DATA FOR NOCICEPTION MONITORING
4.2.1 COMPANY SHARE ANALYSIS
4.2.2 COMPETITIVE LANDSCAPE- FY2019
4.3 COMPANY PROFILING
4.3.1 DOLOSYS GMBH
4.3.1.1 COMPANY SNAPSHOT
4.3.1.2 PRODUCT PORTFOLIO
4.3.1.3 RECENT DEVELOPMENT
4.3.2 MDOLORIS MEDICAL SYSTEMS
4.3.2.1 COMPANY SNAPSHOT
4.3.2.2 PRODUCT PORTFOLIO
4.3.2.3 RECENT DEVELOPMENT
4.3.3 MEDASENSE BIOMETRICS LTD.
4.3.3.1 COMPANY SNAPSHOT
4.3.3.2 PRODUCT PORTFOLIO
4.3.3.3 RECENT DEVELOPMENTs
4.3.4 ALPHA-2
4.3.4.1 COMPANY SNAPSHOT
4.3.4.2 PRODUCT PORTFOLIO
4.3.4.3 RECENT DEVELOPMENT
4.3.5 CEREVU
4.3.5.1 COMPANY SNAPSHOT
4.3.5.2 PRODUCT PORTFOLIO
4.3.5.3 RECENT DEVELOPMENT
4.3.6 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC)
4.3.6.1 COMPANY SNAPSHOT
4.3.6.2 REVENUE ANALYSIS
4.3.6.3 PRODUCT PORTFOLIO
4.3.6.4 RECENT DEVELOPMENT
4.3.7 IDMED
4.3.7.1 COMPANY SNAPSHOT
4.3.7.2 PRODUCT PORTFOLIO
4.3.7.3 RECENT DEVELOPMENT
4.3.8 MED-STORM
4.3.8.1 COMPANY SNAPSHOT
4.3.8.2 PRODUCT PORTFOLIO
4.3.8.3 RECENT DEVELOPMENT
4.4 SALES MODEL AND COMMERCIAL STRATEGY
4.4.1 MEDASENSE BIOMETRICS LTD
4.4.1.1 SALES MODEL
4.4.1.2 COMMERCIAL STRATEGY
4.4.2 MDOLORIS MEDICAL SYSTEMS
4.4.2.1 SALES MODEL
4.4.2.2 COMMERCIAL STRATEGY
4.4.3 IDMED
4.4.3.1 SALES MODEL
4.4.3.2 COMMERCIAL STRATEGY
4.4.4 GE HEALTHCARE ( A SUBSIDIARY OF GENERAL ELECTRIC)
4.4.4.1 SALES MODEL
4.4.4.2 COMMERCIAL STRATEGY
?
4.4.5 MEDSTORM
4.4.5.1 SALES MODEL
4.4.5.2 COMMERCIAL STRATEGY
4.4.6 DOLOSYS GMBH
4.4.6.1 SALES MODEL
4.4.6.2 COMMERCIAL STRATEGY
4.5 SWOT AND DBMR ANALYSIS
4.5.1 STRENGTH: - STRONG PRESENCE AND DISTRIBUTION CHANNEL
4.5.2 WEAKNESS: - LIMITED PRODUCT PORTFOLIO
4.5.3 OPPORTUNITY: - STRATEGIC INITIATIVES
4.5.4 THREAT: - LESS PRODUCT AVAILABILITY
4.6 DATA BRIDGE MARKET RESEARCH ANALYSIS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING GERIATRIC POPULATION
5.1.2 GROWING INCIDENCE & PREVALENCE OF CHRONIC DISEASES
5.1.3 TECHNOLOGICAL ADVANCEMENTS IN ANESTHESIA MONITORING
5.1.4 INCREASING NUMBER OF SURGICAL PROCEDURE
5.2 RESTRAINTS
5.2.1 STRINGENT REGULATIONS
5.2.2 HIGH COST OF DEPTH OF ANESTHESIA MONITORING DEVICES
5.3 OPPORTUNITY
5.3.1 INCREASING HEALTHCARE EXPENDITURE AND INFRASTRUCTURE
5.4 CHALLENGES
5.4.1 LESS ADOPTION IN SMALL OUTPATIENT CENTERS AND CLINICS
5.4.2 LOW LEVEL OF HEALTH SERVICES IN DEVELOPING COUNTRIES
6 ASIA-PACIFIC DEPTH OF ANESTHESIA MONITORING MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 BISPECTRAL INDEX
6.2.1 DEVICES
6.2.2 CONSUMABLES
6.3 PATIENT STATE INDEX (PSI)
6.3.1 DEVICES
6.3.2 CONSUMABLES
6.4 ENTROPY
6.4.1 DEVICES
6.4.2 CONSUMABLES
?
7 ASIA-PACIFIC DEPTH OF ANESTHESIA MONITORING MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 DEVICES
7.2.1 BIS MONITOR
7.2.2 NARCOTREND MONITOR
7.2.3 AEP-MONITOR/2
7.2.4 IOC MONITOR
7.2.5 OTHERS
7.3 CONSUMABLES
7.3.1 CASSETTES
7.3.2 SENSORS
7.3.3 OTHERS
8 ASIA-PACIFIC DEPTH OF ANESTHESIA MONITORING MARKET, BY MODE OF PURCHASE
8.1 OVERVIEW
8.2 GROUP PURCHASING ORGANIZATION
8.3 DIRECT PURCHASE
9 ASIA-PACIFIC DEPTH OF ANESTHESIA MONITORING MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 FLUID MANAGEMENT
9.3 CESAREAN SECTION
9.4 LAPAROSCOPIC SURGERY
9.5 ORTHOPEDIC SURGERY
9.6 VASCULAR SURGERY
9.7 CARDIOLOGICAL INTERVENTIONS
9.8 PEDIATRIC SURGERY
9.9 EMERGENCY MEDICINE
9.10 OTHERS
10 ASIA-PACIFIC DEPTH OF ANESTHESIA MONITORING MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 AMBULATORY SURGICAL CENTERS
10.4 EMERGENCY CENTERS
10.5 CLINICS
10.6 OTHERS
11 ASIA-PACIFIC DEPTH OF ANESTHESIA MONITORING MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
12 ASIA-PACIFIC DEPTH OF ANESTHESIA MONITORING MARKET, BY GEOGRAPHY
12.1 ASIA-PACIFIC
12.1.1 CHINA
12.1.2 JAPAN
12.1.3 INDIA
12.1.4 SOUTH KOREA
12.1.5 AUSTRALIA
12.1.6 SINGAPORE
12.1.7 THAILAND
12.1.8 MALAYSIA
12.1.9 INDONESIA
12.1.10 PHILIPPINES
12.1.11 REST OF ASIA-PACIFIC
13 ASIA-PACIFIC DEPTH OF ANESTHESIA MONITORING MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 COMPANY PROFILE
14.1 MEDTRONIC
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.2 MASIMO
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
?
14.3 DRaGERWERK AG & CO. KGAA
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENT
14.4 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC)
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONCS CO., LTD.
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 FUKUDA DENSHI UK. (A SUBSIDIARY OF FUKUDA DENSHI)
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 COMPANY SHARE ANALYSIS
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT DEVELOPMENT
14.7 CNSYSTEMS MEDIZINTECHNIK GMBH.
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 DANMETER APS
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 EDAN INSTRUMENTS, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.10 GENERAL MEDITECH, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
?
14.11 KONINKLIJKE PHILIPS N.V.
14.11.1 COMPANY SNAPSHOT
14.11.2 REVENUE ANALYSIS
14.11.3 PRODUCT PORTFOLIO
14.11.4 RECENT DEVELOPMENT
14.12 MENNEN MEDICAL LTD.
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 NIHON KOHDEN CORPORATION
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENT
14.14 QUANTIUM MEDICAL, S.L.U.
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 SCHILLER
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 SHENZHEN GEYANG MEDICAL TECHNOLOGY CO., LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 SIARE ENGINEERING INTERNATIONAL GROUP SRL
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 SPACELABS SYSTEMS, INC. (A SUBSIDIARY OF OSI SYSTEMS, INC.)
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENT
14.19 TRITON ELECTRONICS SYSTEMS LTD.
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
?
15 SWOT ANALYSIS AND DATA BRIDGE MARKET RESEARCH ANALYSIS
15.1 SWOT ANALYSIS
15.1.1 STRENGTH: - GENERATING LARGE REVENUE IN MARKET FOCUSED SEGMENT
15.1.1.1 STRENGTH: - STRONG ASIA-PACIFIC PRESENCE
15.1.2 WEAKNESS: - LIMITED PRODUCT PORTFOLIO
15.1.3 OPPORTUNITY: - EXPANDING BUSINESS THOROUGH THEIR SUBSIDIARIES
15.1.3.1 OPPORTUNITY: - STRATEGIC INITIATIVES
15.1.4 THREAT: - CURRENCY CONVERSION
15.2 DATA BRIDGE MARKET RESEARCH ANALYSIS
16 CONCLUSION
17 QUESTIONNAIRE
18 RELATED REPORTS